Short answer
Idexx Laboratories (IDXX) filed its Q1 2025 10-Q quarterly report on May 1, 2025 for the quarter ended Mar 31, 2025. Quarterly revenue was $998M (up 3.6% year over year) with net income of $243M.
Q1 2025 key financials · XBRL
- Revenue
- $998M
- +3.6% YoY
- Net income
- $243M
- +3.0% YoY
- Operating margin
- 31.7%
- Gross margin
- 62.4%
- EPS (diluted)
- $2.96
- +5.3% YoY
Source: XBRL data from the Idexx Laboratories (IDXX) Q1 2025 10-Q on SEC EDGAR. USD.
Idexx Laboratories Q1 2025 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- No profitability or margin figures provided
- No cash position, operating cash flow, or capital deployment changes mentioned
- No management commentary on near-term outlook or updated guidance provided
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other Idexx Laboratories quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.